Gawali Vijay Appu, Dipak A. Joshi, Shyamlila B. Bavage, Nandkishor B. Bavage
Keywords:
Abstract
Purpose; Remdesivir shows promise in the treatment of COVID19 patients. Despite this, it is still necessary to record potential drug side effects (PBL) for future decision-making. Same as the limited ADE data available before the COVID19 pandemic.
Article Details
Unique Paper ID: 152387
Publication Volume & Issue: Volume 8, Issue 3
Page(s): 159 - 161
Article Preview & Download
Share This Article
Conference Alert
NCSST-2021
AICTE Sponsored National Conference on Smart Systems and Technologies
Last Date: 25th November 2021
SWEC- Management
LATEST INNOVATION’S AND FUTURE TRENDS IN MANAGEMENT